Agency Forms Undergoing Paperwork Reduction Act Review, 63394-63395 [2021-24989]
Download as PDF
<![CDATA[
63394
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–1046]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National Breast
and Cervical Cancer Early Detection
Program (NBCCEDP) Monitoring
Activities to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on July 26,
2021 to obtain comments from the
public and affected agencies. CDC
received one non-substantive comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
National Breast and Cervical Cancer
Early Detection Program (NBCCEDP)
Monitoring Activities—(OMB Control
No. 0920–1046, Exp. 11/30/2021)—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a Revision of the
Information Collection Request (ICR)
titled National Breast and Cervical
Cancer Early Detection Program
(NBCCEDP) Monitoring Activities (OMB
Control No. 0920–1046). In the previous
OMB approval period, information
collection consisted of an annual
NBCCEDP survey and clinic-level data
collection. In the next OMB approval
period, information collection will
consist of a revised NBCCEDP survey,
revised clinic-level data collection, new
quarterly program update, new service
delivery projection worksheet, and the
addition of previously approved
minimum data elements (MDEs; OMB
Control No. 0920–0571, Exp. 03/31/
2022) to increase efficiency. The
number of respondents will remain the
same and the total estimated annualized
burden will increase from 683 to 1,228.
Breast and cervical cancers are
prevalent among U.S. women. Evidence
shows that deaths from both breast and
cervical cancers can be avoided by
increasing screening services—
mammography and pap tests—among
women. However, screening is typically
underutilized among women who are
under- or uninsured, have no regular
source of healthcare, or who recently
immigrated to the U.S. To improve
access to cancer screening, Congress
passed the Breast and Cervical Cancer
Mortality Prevention Act of 1990 (Pub.
L. 106–354) which directed CDC to
create the National Breast and Cervical
Cancer Early Detection Program
(NBCCEDP). The NBCCEDP currently
provides funding to 70 awardees under
‘‘Cancer Prevention and Control
Programs for State, Territorial, and
Tribal Organizations (DP17–1701).’’ The
purpose of NBCCEDP is to increase
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
breast and cervical cancer screening
rates among women residing within
defined geographical locations (as
determined by the funded program) who
are at or below 250% of the federal
poverty level; aged 40–64 years for
breast cancer services, and aged 21–64
years for cervical cancer services; and
under- or uninsured.
In 2022, CDC will issue a new Notice
of Funding Opportunity (DP22–2202) to
continue this mission. Consistent with
programmatic changes, the information
collection plan has also been redesigned
to update existing and add new data
collection instruments and integrate the
previously approved MDEs into this
single approval package to increase
efficiency of information collection for
the NBCCEDP.
CDC proposes five forms of
information collection. First, the
NBCCEDP Survey will be submitted to
CDC annually and collects information
to monitor awardees’ TA needs,
partnerships, screening delivery, EBI
implementation, and COVID–19 impact.
Minor revisions to survey questions,
response options, and formatting will be
included under DP22–2202. Second,
clinic-level data will be submitted to
CDC at baseline and annually for all
partnering health system clinic sites—
an estimated six clinics per awardee for
breast cancer data and six clinics per
awardee for cervical cancer data. Cliniclevel data includes health system,
clinic, and patient population
characteristics; monitoring and quality
improvement activities; EBI
implementation; COVID–19 impact, and
baseline or annual screening rates.
Minor revisions were made to variable
wording, formatting (e.g., split or
combined variables), and response
options to improve data quality. Third,
the Quarterly Program Update (QPU)
will be submitted to CDC four times per
year to monitor award spending, service
delivery, staff vacancies, and program
accomplishments and challenges. This
is a new information collection. Fourth,
the Service Delivery Projection
Worksheet will be submitted to CDC
annually to report the estimated number
of women to be served for breast and
cervical cancer. Finally, the Minimum
Data Elements (MDEs) will be submitted
to CDC twice per year to monitor patient
demographics; breast and cervical
cancer screening, diagnosis, and
treatment; timeliness of services; and
patient navigation. This information
collection was previously approved
(OMB Control No. 0920–0571, Exp. 03/
30/2022) and will now be incorporated
into this OMB approved package for
increased efficiency for NBCCEDP
information collection efforts.
E:\FR\FM\16NON1.SGM
16NON1
63395
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
This revised information collection
will allow CDC to provide routine
monitoring feedback to awardees based
on their data submissions, tailor
technical assistance (TA) as needed,
support program planning, and assess
program outcomes. OMB approval is
requested for three years. Participation
is required for NBCCEDP awardees.
There are no costs to respondents other
than their time. The total estimated
annual burden is 1,228 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
NBCCEDP Awardees .............
Annual NBCCEDP Survey .....................................................
NBCCEDP Clinic-level Information Collection Instrument—
Breast.
NBCCEDP Clinic-level Information Collection Instrument—
Cervical.
Quarterly Program Update .....................................................
Service Delivery Projection Worksheet ..................................
MDEs ......................................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–24989 Filed 11–15–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–1105; Docket No. CDC–2021–
0117]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled the One Health Harmful Algal
Bloom System (OHHABS). OHHABS is
a surveillance platform which captures
data on harmful algal bloom (HAB)
events and HAB-associated illnesses.
DATES: CDC must receive written
comments on or before January 18,
2022.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
You may submit comments,
identified by Docket No. CDC–2021–
0117 by any of the following methods:
ADDRESSES:
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hrs)
70
70
1
6
56/60
45/60
70
6
45/60
70
70
70
4
1
2
32/60
29/60
150/60
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
One Health Harmful Algal Bloom
System (OHHABS) (OMB Control No.
0920–1105, Exp. 3/31/2022)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Algal toxins from harmful algal
blooms (HABs) include some of the
most potent natural chemicals. These
toxins can contaminate surface water
used for recreation and drinking, as well
as food sources, and HABs pose a threat
to both humans and animals. Because
animal illness may be an indicator of
bloom toxicity, it is necessary to provide
a One Health approach for reporting
HAB-associated illnesses and events.
E:\FR\FM\16NON1.SGM
16NON1
]]>Agencies
[Federal Register Volume 86, Number 218 (Tuesday, November 16, 2021)]
[Notices]
[Pages 63394-63395]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24989]
[[Page 63394]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-1046]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) Monitoring Activities to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on July 26, 2021 to obtain comments from the
public and affected agencies. CDC received one non-substantive comment
related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Breast and Cervical Cancer Early Detection Program
(NBCCEDP) Monitoring Activities--(OMB Control No. 0920-1046, Exp. 11/
30/2021)--Revision--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting a Revision of the Information Collection Request
(ICR) titled National Breast and Cervical Cancer Early Detection
Program (NBCCEDP) Monitoring Activities (OMB Control No. 0920-1046). In
the previous OMB approval period, information collection consisted of
an annual NBCCEDP survey and clinic-level data collection. In the next
OMB approval period, information collection will consist of a revised
NBCCEDP survey, revised clinic-level data collection, new quarterly
program update, new service delivery projection worksheet, and the
addition of previously approved minimum data elements (MDEs; OMB
Control No. 0920-0571, Exp. 03/31/2022) to increase efficiency. The
number of respondents will remain the same and the total estimated
annualized burden will increase from 683 to 1,228.
Breast and cervical cancers are prevalent among U.S. women.
Evidence shows that deaths from both breast and cervical cancers can be
avoided by increasing screening services--mammography and pap tests--
among women. However, screening is typically underutilized among women
who are under- or uninsured, have no regular source of healthcare, or
who recently immigrated to the U.S. To improve access to cancer
screening, Congress passed the Breast and Cervical Cancer Mortality
Prevention Act of 1990 (Pub. L. 106-354) which directed CDC to create
the National Breast and Cervical Cancer Early Detection Program
(NBCCEDP). The NBCCEDP currently provides funding to 70 awardees under
``Cancer Prevention and Control Programs for State, Territorial, and
Tribal Organizations (DP17-1701).'' The purpose of NBCCEDP is to
increase breast and cervical cancer screening rates among women
residing within defined geographical locations (as determined by the
funded program) who are at or below 250% of the federal poverty level;
aged 40-64 years for breast cancer services, and aged 21-64 years for
cervical cancer services; and under- or uninsured.
In 2022, CDC will issue a new Notice of Funding Opportunity (DP22-
2202) to continue this mission. Consistent with programmatic changes,
the information collection plan has also been redesigned to update
existing and add new data collection instruments and integrate the
previously approved MDEs into this single approval package to increase
efficiency of information collection for the NBCCEDP.
CDC proposes five forms of information collection. First, the
NBCCEDP Survey will be submitted to CDC annually and collects
information to monitor awardees' TA needs, partnerships, screening
delivery, EBI implementation, and COVID-19 impact. Minor revisions to
survey questions, response options, and formatting will be included
under DP22-2202. Second, clinic-level data will be submitted to CDC at
baseline and annually for all partnering health system clinic sites--an
estimated six clinics per awardee for breast cancer data and six
clinics per awardee for cervical cancer data. Clinic-level data
includes health system, clinic, and patient population characteristics;
monitoring and quality improvement activities; EBI implementation;
COVID-19 impact, and baseline or annual screening rates. Minor
revisions were made to variable wording, formatting (e.g., split or
combined variables), and response options to improve data quality.
Third, the Quarterly Program Update (QPU) will be submitted to CDC four
times per year to monitor award spending, service delivery, staff
vacancies, and program accomplishments and challenges. This is a new
information collection. Fourth, the Service Delivery Projection
Worksheet will be submitted to CDC annually to report the estimated
number of women to be served for breast and cervical cancer. Finally,
the Minimum Data Elements (MDEs) will be submitted to CDC twice per
year to monitor patient demographics; breast and cervical cancer
screening, diagnosis, and treatment; timeliness of services; and
patient navigation. This information collection was previously approved
(OMB Control No. 0920-0571, Exp. 03/30/2022) and will now be
incorporated into this OMB approved package for increased efficiency
for NBCCEDP information collection efforts.
[[Page 63395]]
This revised information collection will allow CDC to provide
routine monitoring feedback to awardees based on their data
submissions, tailor technical assistance (TA) as needed, support
program planning, and assess program outcomes. OMB approval is
requested for three years. Participation is required for NBCCEDP
awardees. There are no costs to respondents other than their time. The
total estimated annual burden is 1,228 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hrs)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees................... Annual NBCCEDP Survey...... 70 1 56/60
NBCCEDP Clinic-level 70 6 45/60
Information Collection
Instrument--Breast.
NBCCEDP Clinic-level 70 6 45/60
Information Collection
Instrument--Cervical.
Quarterly Program Update... 70 4 32/60
Service Delivery Projection 70 1 29/60
Worksheet.
MDEs....................... 70 2 150/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-24989 Filed 11-15-21; 8:45 am]
BILLING CODE 4163-18-P
